Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

13.51 +0.56 (+4.29%)
Streaming Delayed Price Updated: 12:36 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
34 35 Next >
Psychedelic Stock Gainers And Losers From November 21, 2022 ↗
 
Via Benzinga
News headline image
Psychedelic Drug Stocks Index Continued To Decline Last Week ↗
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter... 
Via Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022 ↗
 
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Mind Medicine’s Bad Trip Won’t End Anytime Soon ↗
Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup ↗
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics 
Via Benzinga
News headline image
Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls
From Concerned Shareholders of Company MindMed
Via GlobeNewswire
News headline image
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8% ↗
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic... 
Via Talk Markets
News headline image
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials ↗
Clinical-stage biotech company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results and updated on its programs pipeline of the third quarter ended September 30, 2022. 
Via Benzinga
News headline image
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05 
Via Benzinga
News headline image
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From November 8, 2022 ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14 
Via Benzinga
News headline image
The Psychedelic Drug Stocks Index Continued To Plummet Last Week ↗
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. 
Via Talk Markets
News headline image
Compass Pathways, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From November 3, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27 
Via Benzinga
News headline image
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S. ↗
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis... 
Via Benzinga
News headline image
Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct
From Concerned Shareholders of Company MindMed
Via GlobeNewswire
News headline image
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS: 
Via Benzinga
News headline image
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov. ↗
While penny stocks are highly speculative and risky, you may still want to consider these seven opportunities. 
Via InvestorPlace
News headline image
October Recap: Major Psychedelic Drug Stocks Declined 9.9% ↗
In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD. 
Via Talk Markets
News headline image
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 26, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 25, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39 
Via Benzinga
News headline image
Cannabis Category Performances Ranged From +14.4% To -4.6% This Past Week ↗
The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since... 
Via Talk Markets
News headline image
Allied, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53 
Via Benzinga
News headline image
Why Mind Medicine Zoomed 8% Higher on Tuesday ↗
The support for legalizing drugs -- such as those being studied by the company -- grows with a U.S. senator's tweet. 
Via The Motley Fool
News headline image
Psychedelic Stock Gainers And Losers From October 18, 2022 ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.